Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Durrieu

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|March 27, 2007
Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological courseG Durrieu, C Hurault, V Bongard, et al.
Clinical Neuropharmacology|February 1, 1991
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsoniansG Durrieu, J M Senard, M A Tran, et al.
Journal of Clinical Pharmacology|October 1, 1996
Effects of befloxatone, a reversible selective monoamine oxidase-A inhibitor, on psychomotor function and memory in healthy subjectsD Warot, I Berlin, A Patat, et al.
Molecular and Cellular Biochemistry|October 6, 1997
Identification of mitochondrial deficiency using principal component analysisG Durrieu, T Letellier, J Antoch, et al.
Journal of Clinical Pharmacology|June 1, 1995
Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjectsA Patat, I Berlin, G Durrieu, et al.
Journal of Affective Disorders|May 20, 1999
Clinical pharmacology of befloxatone: a brief reviewP Rosenzweig, A Patat, O Curet, et al.
European Journal of Clinical Pharmacology|October 12, 2014
Use of administrative hospital database to identify adverse drug reactions in a Pediatric University HospitalG Durrieu, A Batz, V Rousseau, et al.
Clinical Neuropharmacology|December 1, 1990
Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatmentG Durrieu, Y Rispail, E Chatelut, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 1, 1992
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessmentG Durrieu, M E LLau, O Rascol, et al.
British Journal of Pharmacology|September 1, 1995
Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogsC Damase-Michel, G Bompart, G Durrieu, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|March 27, 2007
Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological courseG Durrieu, C Hurault, V Bongard, et al.
Clinical Neuropharmacology|February 1, 1991
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsoniansG Durrieu, J M Senard, M A Tran, et al.
Journal of Clinical Pharmacology|October 1, 1996
Effects of befloxatone, a reversible selective monoamine oxidase-A inhibitor, on psychomotor function and memory in healthy subjectsD Warot, I Berlin, A Patat, et al.
Molecular and Cellular Biochemistry|October 6, 1997
Identification of mitochondrial deficiency using principal component analysisG Durrieu, T Letellier, J Antoch, et al.
Journal of Clinical Pharmacology|June 1, 1995
Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjectsA Patat, I Berlin, G Durrieu, et al.
Journal of Affective Disorders|May 20, 1999
Clinical pharmacology of befloxatone: a brief reviewP Rosenzweig, A Patat, O Curet, et al.
European Journal of Clinical Pharmacology|October 12, 2014
Use of administrative hospital database to identify adverse drug reactions in a Pediatric University HospitalG Durrieu, A Batz, V Rousseau, et al.
Clinical Neuropharmacology|December 1, 1990
Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatmentG Durrieu, Y Rispail, E Chatelut, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 1, 1992
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessmentG Durrieu, M E LLau, O Rascol, et al.
British Journal of Pharmacology|September 1, 1995
Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogsC Damase-Michel, G Bompart, G Durrieu, et al.
Pageof 4